Transplantation of retinoic acid treated murine embryonic stem cells & behavioural deficit in Parkinsonian rats

Indian Journal of Medical Research

Volumn 131, Issue 4, 2010, Pages 536-544

  Fathi, Fardin ^a   Altiraihi, Taki ^b   Mowla, Seyed Javad ^b   Movahedin, Mansoreh ^b  

^a KURDISTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

Embryonic stem cells; Parkinson's disease; Retinoic acid; Transplantation

Indexed keywords

CYCLOSPORIN A; RETINOIC ACID; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; EMBRYONIC STEM CELL; ENGRAFTMENT; FEMALE; GRAFT REJECTION; LOCOMOTION; MOTOR DYSFUNCTION; MOUSE; NERVE CELL CULTURE; NERVE REGENERATION; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; PARKINSONISM; RAT; THERAPY EFFECT;

ANIMALS; BEHAVIOR, ANIMAL; BROMODEOXYURIDINE; EMBRYONIC STEM CELLS; FEMALE; MICE; PARKINSONIAN DISORDERS; RATS; RATS, SPRAGUE-DAWLEY; STEM CELL TRANSPLANTATION;

EID: 77951063407     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Arenas E. Stem cells in the treatment of Parkinson's disease. Brain Res Bull 2002; 57: 795-808.
2. Nishimura F, Yoshikawa M, Kanda S, Nonaka M, Yokota H, Shiroi H, et al. Potential use of embryonic stem cells for the treatment of mouse Parkinsonian models: Improved behavior by transplantation of in vitro differentiated dopaminergic neurons from embryonic stem cells. Stem Cells 2003; 21: 171-80.
3. Tanner CM, Goldman SM, Ross GW. Etiology of Parkinson's disease. In: Jankovic JJ, Tolosa E, editor. Parkinson's disease and movement disorders. 4th ed. Philadelphia, USA: Lippincott,Williams and Wilkins; 2002. p. 90-114.
4. Takahashi M, Yamada T. Viral etiology for Parkinson's disease-A possible role of influenza A virus infection. Jpn J Infect Dis 1999; 52: 89-98.
5. Dunnett SB, Björklund A, Lindvall O. Cell therapy in Parkinson's disease-Stop or go?. Nat Rev Neurosci 2001; 2: 365-9.
6. Wagner J, Akerud P, Castro DS, Holm PC, Canals JM, Snyder EY, et al. Induction of a midbrain dopaminergic phenotype in Nurr1-overexpressing neural stem cells by type 1 astrocytes. Nat Biotechnol 1999; 17: 653-9.
7. Bjorklund LM, Sanchez-Pernaute R, Chung S, Andersson T, Chen IY, McNaught KS, et al. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci USA 2002; 99: 2344-9.
8. Deacon T, Dinsmore J, Costantini LC, Ratliff J, Isacson O. Blastula-stage stem cells can differentiate into dopaminergic and serotonergic neurons after transplantation. Exp Neurol 1998; 149: 28-41.
9. Kim JH, Auerbach JM, Rodriguez-Gomez JA, Velasco I, Gavin D, Lumelsky N, et al. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 2002; 418: 50-6.
10. Wobus AM, Grosse R, Schoneich J. Specific effects of nerve growth factor on the differentiation pattern of mouse embryonic stem cells in vitro. Biomed Biochim Acta 1988; 47: 965-73.
11. Wobus AM, Rohwedel J, Maltsev V, Hescheler J. In vitro differentiation of embryonic stem cells into cardiomyocytes or skeletal muscle cells is specifically modulated by retinoic acid. Roux's Arch Dev Biol 1994; 204: 36-45.
12. Bain G, Kitchens D, Yao M, Huettner JE, Gottlieb DI. Embryonic stem cells express neuronal properties in vitro. Dev Biol 1995; 168: 342-57.
13. Strubing C, Ahnert-Hilger G, Shan J, Wiedenmann B, Hescheler J, Wobus AM. Differentiation of pluripotent embryonic stem cells into the neuronal lineage in vitro gives rise to mature inhibitory and excitatory neurons. Mech Dev 1995; 53: 275-8.
14. Grantyn R, Perouansky M, Rodriguez-Tebar A, Lux HD. Expression of depolarizing voltage- and transmitter-activated currents in neuronal precursor cells from the rat brain is preceded by proton-activated sodium current. Brain Res Dev Brain Res 1989; 49: 150-5.
15. Lee SH, Lumelsky N, Studer L, Auerbach JM, McKay RD. Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat Biotech 2000; 18: 675-9.
16. Kim DW, Chung S, Hwang M, Ferree A, Tsai HC, Park JJ, et al. Stromal cell-derived inducing activity, Nurr1 and signaling molecules synergistically induce dopaminergic neurons from mouse embryonic stem cells. Stem cells 2005; 24: 557-67.
17. Kawasaki H, Mizuseki K, Nishikawa S, Kaneko S, Kuwana Y, Nakanishi S, et al. Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron 2000; 28: 31-40.
18. Chung S, Sonntag KC, Andersson T, Bjorklund LM, Park JJ, Kim DW, et al. Genetic engineering of mouse embryonic stem cells by Nurr1 enhances differentiation and maturation into dopaminergic neurons. Eur J Neurosci 2002; 16: 1829-38.
19. Hitoshi S, Seaberg RM, Koscik C, Alexson T, Kusunoki S, Kanazawa I, et al. Primitive neural stem cells from the mammalian epiblast differentiate to definitive neural stem cells under the control of Notch signaling. Genes Dev 2004; 18: 1806-11.
20. Chung S, Shin BS, Hwang M, Lardaro T, Kang UJ, Isacson O, et al. Fetal ventral mesencephalon, maintain the potential to differentiate into neural precursors derived from embryonic stem cells, but not those from dopaminergic neurons after expansion in vitro. Stem Cells 2006; 24: 1583-93.
21. Roghani M, Behzadi G. Neuroprotective effect of vitamin E on the early model of Parkinson's disease in rat: behavioral and histochemical evidence. Brain Res 2001; 892: 211-7.
22. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 2nd ed. San Diego: Academic Press, 1986. p. 1-100.
23. Zheng JS, Tang LL, Zheng SS, Zhan RY, Zhou YQ, Goudreau J, et al. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease. Brain Res Mol Brain Res 2005; 134: 155-61.
24. Fathi F, Altiraihi T, Mowla SJ, Movahedin M. Transfection of CCE mouse embryonic stem cells with EGFP and BDNF genes by the electroporation method. Rejuvenation Res 2006; 9: 26-30.
25. Wilkins A, Chandran S, Compston A. A role for oligodendrocyte-derived IGF-1 in trophic support of cortical neurons. Glia 2001; 36: 48-57.
26. Takeshima T, Johnstone JM, Commissiong JW. O-2A progenitors increase the survival of rat mesencephalic, dopaminergic neurons from death induced by serum deprivation. Neurosci Lett 1994; 166: 178-82.
27. Goldman S. Stem and progenitor cell-based therapy of the human central nervous system. Nat Biotechnol 2005; 23: 862-71.
28. Lindvall O, Hagell P. Role of cell therapy in Parkinson disease. Neurosurg Focus 2002; 13: e2.
29. Levy YS, Stroomza M, Melamed E, Offen D. Embryonic and adult stem cells as a source for cell therapy in Parkinson's disease. J Mol Neurosci 2004; 24: 353-86.
30. Sonntag KC, Simantov R, Isacson O. Stem cells may reshape the prospect of Parkinson's disease therapy. Brain Res Mol Brain Res 2005; 134: 34-51.
31. Coyne TM, Marcus AJ, Woodbury D, Black IB. The marrow stromal cells transplanted to the adult brain are rejected by an inflammatory response and transfer donor labels to host neurons and glia. Stem Cells 2006; 24: 2483-92.